https://medicalxpress.com/news/2023-04-clinical-trial-paxlovid-effectiveness-covid.html
Iwasaki and Krumholz are finally beginning their trial of Paxlovid and Long Covid. Not sure 15 days is enough but maybe this trial will move things along and perhaps bring some clarity to the general question of viral persistence in Long Covid. A successful trial would be a step in the right direction for looking for the same in ME.
"There are a number of other similar post-acute infection syndromes that happen after many different virus infections and some bacteria and parasitic infections," says Iwasaki. "The fact that the downstream consequences, including myalgic encephalomyelitis, are so similar to each other makes us believe that once we figure out one of these syndromes, we can apply a similar insight into other post-acute phase diseases."
Chris
Iwasaki and Krumholz are finally beginning their trial of Paxlovid and Long Covid. Not sure 15 days is enough but maybe this trial will move things along and perhaps bring some clarity to the general question of viral persistence in Long Covid. A successful trial would be a step in the right direction for looking for the same in ME.
"There are a number of other similar post-acute infection syndromes that happen after many different virus infections and some bacteria and parasitic infections," says Iwasaki. "The fact that the downstream consequences, including myalgic encephalomyelitis, are so similar to each other makes us believe that once we figure out one of these syndromes, we can apply a similar insight into other post-acute phase diseases."
Chris
Last edited: